Invention Grant
- Patent Title: Anti-VCAM-1 nanobodies
-
Application No.: US14240340Application Date: 2012-08-22
-
Publication No.: US09771423B2Publication Date: 2017-09-26
- Inventor: Catherine Ghezzi , Daniel Fagret , Alexis Broisat , Nick Devoogdt , Tony Lahoutte , Serge Muydermans
- Applicant: Catherine Ghezzi , Daniel Fagret , Alexis Broisat , Nick Devoogdt , Tony Lahoutte , Serge Muydermans
- Applicant Address: BE Brussel FR La Tronche FR Saint Martin D'Heres
- Assignee: VIRJE UNIVERSITEIT BRUSSEL,CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE,UNIVERSITE GRENOBLE ALPES
- Current Assignee: VIRJE UNIVERSITEIT BRUSSEL,CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE,UNIVERSITE GRENOBLE ALPES
- Current Assignee Address: BE Brussel FR La Tronche FR Saint Martin D'Heres
- Agency: Knobbe, Martens Olson & Bear, LLP
- Priority: FR1157478 20110823
- International Application: PCT/EP2012/066348 WO 20120822
- International Announcement: WO2013/026878 WO 20130228
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K51/10 ; G01N33/68
Abstract:
The present invention relates to nanobodies specifically directed against VCAM-1 and to their use in medical imaging and in diagnostic, prognostic and treatment methods.
Public/Granted literature
- US20140255303A1 ANTI-VCAM-1 NANOBODIES Public/Granted day:2014-09-11
Information query
